Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 19494218)

1.

An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.

Aksentijevich I, Masters SL, Ferguson PJ, Dancey P, Frenkel J, van Royen-Kerkhoff A, Laxer R, Tedgård U, Cowen EW, Pham TH, Booty M, Estes JD, Sandler NG, Plass N, Stone DL, Turner ML, Hill S, Butman JA, Schneider R, Babyn P, El-Shanti HI, Pope E, Barron K, Bing X, Laurence A, Lee CC, Chapelle D, Clarke GI, Ohson K, Nicholson M, Gadina M, Yang B, Korman BD, Gregersen PK, van Hagen PM, Hak AE, Huizing M, Rahman P, Douek DC, Remmers EF, Kastner DL, Goldbach-Mansky R.

N Engl J Med. 2009 Jun 4;360(23):2426-37. doi: 10.1056/NEJMoa0807865.

2.

An autoinflammatory disease due to homozygous deletion of the IL1RN locus.

Reddy S, Jia S, Geoffrey R, Lorier R, Suchi M, Broeckel U, Hessner MJ, Verbsky J.

N Engl J Med. 2009 Jun 4;360(23):2438-44. doi: 10.1056/NEJMoa0809568.

3.

A novel mutation of IL1RN in the deficiency of interleukin-1 receptor antagonist syndrome: description of two unrelated cases from Brazil.

Jesus AA, Osman M, Silva CA, Kim PW, Pham TH, Gadina M, Yang B, Bertola DR, Carneiro-Sampaio M, Ferguson PJ, Renshaw BR, Schooley K, Brown M, Al-Dosari A, Al-Alami J, Sims JE, Goldbach-Mansky R, El-Shanti H.

Arthritis Rheum. 2011 Dec;63(12):4007-17. doi: 10.1002/art.30588.

4.

Mutation screening of the IL-1 receptor antagonist gene in chronic non-bacterial osteomyelitis of childhood and adolescence.

Beck C, Girschick HJ, Morbach H, Schwarz T, Yimam T, Frenkel J, van Gijn ME.

Clin Exp Rheumatol. 2011 Nov-Dec;29(6):1040-3. Epub 2011 Dec 22.

PMID:
22032624
5.

Interleukin-1beta and the autoinflammatory diseases.

Dinarello CA.

N Engl J Med. 2009 Jun 4;360(23):2467-70. doi: 10.1056/NEJMe0811014. No abstract available.

PMID:
19494224
6.

Interleukin 1 receptor antagonist deficiency presenting as infantile pustulosis mimicking infantile pustular psoriasis.

Minkis K, Aksentijevich I, Goldbach-Mansky R, Magro C, Scott R, Davis JG, Sardana N, Herzog R.

Arch Dermatol. 2012 Jun;148(6):747-52. doi: 10.1001/archdermatol.2011.3208.

7.

The first reported case of compound heterozygous IL1RN mutations causing deficiency of the interleukin-1 receptor antagonist.

Stenerson M, Dufendach K, Aksentijevich I, Brady J, Austin J, Reed AM.

Arthritis Rheum. 2011 Dec;63(12):4018-22. doi: 10.1002/art.30565.

8.

[DIRA: life-threatening but treatable inherited inflammatory disease].

ter Haar NM, van Royen A, van Gijn ME, Frenkel J.

Ned Tijdschr Geneeskd. 2010;154:A1601. Dutch.

PMID:
20482912
9.

Treating inflammation by blocking interleukin-1 in humans.

Dinarello CA, van der Meer JW.

Semin Immunol. 2013 Dec 15;25(6):469-84. doi: 10.1016/j.smim.2013.10.008. Epub 2013 Nov 23. Review.

10.

A novel mutation in the interleukin-1 receptor antagonist associated with intrauterine disease onset.

Altiok E, Aksoy F, Perk Y, Taylan F, Kim PW, Ilıkkan B, Asal GT, Goldbach-Mansky R, Sanal O.

Clin Immunol. 2012 Oct;145(1):77-81. doi: 10.1016/j.clim.2012.08.003. Epub 2012 Aug 16.

11.

Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?

Picco P, Brisca G, Traverso F, Loy A, Gattorno M, Martini A.

Arthritis Rheum. 2009 Jan;60(1):264-8. doi: 10.1002/art.24174.

12.

First clinical description of an infant with interleukin-36-receptor antagonist deficiency successfully treated with anakinra.

Rossi-Semerano L, Piram M, Chiaverini C, De Ricaud D, Smahi A, Koné-Paut I.

Pediatrics. 2013 Oct;132(4):e1043-7. doi: 10.1542/peds.2012-3935. Epub 2013 Sep 9.

13.

Deficiency of interleukin-1 receptor antagonist responsive to anakinra.

Schnellbacher C, Ciocca G, Menendez R, Aksentijevich I, Goldbach-Mansky R, Duarte AM, Rivas-Chacon R.

Pediatr Dermatol. 2013 Nov-Dec;30(6):758-60. doi: 10.1111/j.1525-1470.2012.01725.x. Epub 2012 Apr 4.

14.

Interleukin-1 receptor antagonist deficiency with a novel mutation; late onset and successful treatment with canakinumab: a case report.

Ulusoy E, Karaca NE, El-Shanti H, Kilicoglu E, Aksu G, Kutukculer N.

J Med Case Rep. 2015 Jun 23;9(1):145. [Epub ahead of print]

15.

Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.

Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI, Kim HJ, Brewer C, Zalewski C, Wiggs E, Hill S, Turner ML, Karp BI, Aksentijevich I, Pucino F, Penzak SR, Haverkamp MH, Stein L, Adams BS, Moore TL, Fuhlbrigge RC, Shaham B, Jarvis JN, O'Neil K, Vehe RK, Beitz LO, Gardner G, Hannan WP, Warren RW, Horn W, Cole JL, Paul SM, Hawkins PN, Pham TH, Snyder C, Wesley RA, Hoffmann SC, Holland SM, Butman JA, Kastner DL.

N Engl J Med. 2006 Aug 10;355(6):581-92.

16.

Anakinra prevents symptoms of familial cold autoinflammatory syndrome and Raynaud's disease.

Metyas SK, Hoffman HM.

J Rheumatol. 2006 Oct;33(10):2085-7. Epub 2006 Sep 15.

PMID:
16981288
17.

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.

Dinarello CA, Simon A, van der Meer JW.

Nat Rev Drug Discov. 2012 Aug;11(8):633-52. doi: 10.1038/nrd3800. Review.

18.

Homeostatic tissue responses in skin biopsies from NOMID patients with constitutive overproduction of IL-1β.

Aubert P, Suárez-Fariñas M, Mitsui H, Johnson-Huang LM, Harden JL, Pierson KC, Dolan JG, Novitskaya I, Coats I, Estes J, Cowen EW, Plass N, Lee CC, Sun HW, Lowes MA, Goldbach-Mansky R.

PLoS One. 2012;7(11):e49408. doi: 10.1371/journal.pone.0049408. Epub 2012 Nov 30.

19.

Two pathogenic CIAS1 mutations and plasma cytokine profile in a Finnish patient with familial cold autoinflammatory syndrome responsive to anakinra.

Kaipiainen-Seppänen O, Punnonen K, van Gijn ME, Mononen T.

Scand J Rheumatol. 2008 Jan-Feb;37(1):75-6. doi: 10.1080/03009740701691491. No abstract available.

PMID:
18189199
20.

Response to IL-1-receptor antagonist in a child with familial cold autoinflammatory syndrome.

O'Connell SM, O'Regan GM, Bolger T, Hoffman HM, Cant A, Irvine AD, Watson RM.

Pediatr Dermatol. 2007 Jan-Feb;24(1):85-9.

PMID:
17300660
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk